Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach.

Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach. — المؤلف: Sluiter, Reinier L — European addiction research 20190307

المؤلف
Sluiter, Reinier L
النشر
European addiction research 20190307
الوصف
245-254 p.
الموضوعات
Acamprosate؛ Alcoholism؛ Alleles؛ Computer Simulation؛ Cost-Benefit Analysis؛ Genotype؛ Health Care Costs؛ Humans